PL3066108T3 - Octan 4-{4-[(1E)-4-(2,9-diazaspiro[5.5]undec-2-yIo)but-1-en-1-ylo]-2-metylobenzylo}-5-(propan-2-ylo)-1H-pirazol-3-ilo beta-D-glukopiranozydu - Google Patents
Octan 4-{4-[(1E)-4-(2,9-diazaspiro[5.5]undec-2-yIo)but-1-en-1-ylo]-2-metylobenzylo}-5-(propan-2-ylo)-1H-pirazol-3-ilo beta-D-glukopiranozyduInfo
- Publication number
- PL3066108T3 PL3066108T3 PL14802974T PL14802974T PL3066108T3 PL 3066108 T3 PL3066108 T3 PL 3066108T3 PL 14802974 T PL14802974 T PL 14802974T PL 14802974 T PL14802974 T PL 14802974T PL 3066108 T3 PL3066108 T3 PL 3066108T3
- Authority
- PL
- Poland
- Prior art keywords
- diazaspiro
- undec
- methylbenzyl
- pyrazol
- propan
- Prior art date
Links
- LVPGRGRCROHTBW-UULRIGGJSA-N (2s,3r,4s,5s,6r)-2-[[4-[[4-[(e)-4-(2,9-diazaspiro[5.5]undecan-2-yl)but-1-enyl]-2-methylphenyl]methyl]-5-propan-2-yl-1h-pyrazol-3-yl]oxy]-6-(hydroxymethyl)oxane-3,4,5-triol Chemical compound C=1C=C(\C=C\CCN2CC3(CCNCC3)CCC2)C=C(C)C=1CC1=C(C(C)C)NN=C1O[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O LVPGRGRCROHTBW-UULRIGGJSA-N 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D221/00—Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups C07D211/00 - C07D219/00
- C07D221/02—Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups C07D211/00 - C07D219/00 condensed with carbocyclic rings or ring systems
- C07D221/20—Spiro-condensed ring systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H17/00—Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals
- C07H17/02—Heterocyclic radicals containing only nitrogen as ring hetero atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
- A61K31/7052—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
- A61K31/7056—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing five-membered rings with nitrogen as a ring hetero atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/48—Drugs for disorders of the endocrine system of the pancreatic hormones
- A61P5/50—Drugs for disorders of the endocrine system of the pancreatic hormones for increasing or potentiating the activity of insulin
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
- C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
- C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D231/14—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D309/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings
- C07D309/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
- C07D309/04—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
- C07D309/06—Radicals substituted by oxygen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
- C07B2200/00—Indexing scheme relating to specific properties of organic compounds
- C07B2200/13—Crystalline forms, e.g. polymorphs
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Diabetes (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Molecular Biology (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biochemistry (AREA)
- Biotechnology (AREA)
- Genetics & Genomics (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Endocrinology (AREA)
- Epidemiology (AREA)
- Emergency Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Saccharide Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201361901488P | 2013-11-08 | 2013-11-08 | |
| EP14802974.7A EP3066108B1 (en) | 2013-11-08 | 2014-10-30 | 4-{4-[(1e)-4-(2,9-diazaspiro[5.5]undec-2-yl)but-1-en-1-yl]-2-methylbenzyl}-5-(propan-2-yl)-1h-pyrazol-3-yl beta-d- glucopyranoside acetate |
| PCT/US2014/063161 WO2015069541A1 (en) | 2013-11-08 | 2014-10-30 | 4-{4-[(1 e)-4-(2,9-diazaspiro[5.5]undec-2-yl)but-1 -en-1 -yl]-2-methylbenzyl}-5-(propan-2-yl)-1 h-pyrazol-3-yl beta-d- glucopyranoside acetate |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PL3066108T3 true PL3066108T3 (pl) | 2019-03-29 |
Family
ID=51982747
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PL14802974T PL3066108T3 (pl) | 2013-11-08 | 2014-10-30 | Octan 4-{4-[(1E)-4-(2,9-diazaspiro[5.5]undec-2-yIo)but-1-en-1-ylo]-2-metylobenzylo}-5-(propan-2-ylo)-1H-pirazol-3-ilo beta-D-glukopiranozydu |
Country Status (35)
| Country | Link |
|---|---|
| US (1) | US9573970B2 (pl) |
| EP (1) | EP3066108B1 (pl) |
| JP (1) | JP6197113B2 (pl) |
| KR (1) | KR101858881B1 (pl) |
| CN (1) | CN105705509B (pl) |
| AP (1) | AP2016009180A0 (pl) |
| AR (2) | AR098670A1 (pl) |
| AU (1) | AU2014347065B2 (pl) |
| CA (1) | CA2925128C (pl) |
| CL (1) | CL2016000791A1 (pl) |
| CR (1) | CR20160165A (pl) |
| CY (1) | CY1121096T1 (pl) |
| DK (1) | DK3066108T3 (pl) |
| DO (1) | DOP2016000067A (pl) |
| EA (1) | EA028801B1 (pl) |
| ES (1) | ES2703944T3 (pl) |
| HR (1) | HRP20182061T1 (pl) |
| IL (1) | IL244899B (pl) |
| JO (1) | JO3485B1 (pl) |
| LT (1) | LT3066108T (pl) |
| MA (1) | MA39019A1 (pl) |
| MX (1) | MX368174B (pl) |
| MY (1) | MY192242A (pl) |
| NZ (1) | NZ718118A (pl) |
| PE (1) | PE20160884A1 (pl) |
| PH (1) | PH12016500851B1 (pl) |
| PL (1) | PL3066108T3 (pl) |
| PT (1) | PT3066108T (pl) |
| RS (1) | RS58050B1 (pl) |
| SI (1) | SI3066108T1 (pl) |
| SV (1) | SV2016005190A (pl) |
| TN (1) | TN2016000112A1 (pl) |
| TW (1) | TWI655198B (pl) |
| UA (1) | UA118767C2 (pl) |
| WO (1) | WO2015069541A1 (pl) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2975432A1 (en) * | 2015-02-13 | 2016-08-18 | Transgene Sa | Immunotherapeutic vaccine and antibody combination therapy |
| CA3065386A1 (en) * | 2017-06-12 | 2018-12-20 | Lignamed, Llc | Process for the preparation of (s,s)-secoisolariciresinol diglucoside and (r,r)-secoisolariciresinol diglucoside |
| CN110054657B (zh) | 2018-01-18 | 2021-06-29 | 亚宝药业集团股份有限公司 | 吡喃葡萄糖取代的吡唑化合物及其制备方法 |
Family Cites Families (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP1213296B1 (en) | 1999-08-31 | 2004-04-14 | Kissei Pharmaceutical Co., Ltd. | Glucopyranosyloxypyrazole derivatives, medicinal compositions containing the same and intermediates in the production thereof |
| EP1364957B1 (en) | 2001-02-26 | 2008-12-31 | Kissei Pharmaceutical Co., Ltd. | Glycopyranosyloxypyrazole derivatives and medicinal use thereof |
| CA2448741C (en) | 2001-05-30 | 2010-06-22 | Kissei Pharmaceutical Co., Ltd. | Glucopyranosyloxypyrazole derivative, medicinal composition containing the same, medicinal use thereof, and intermediate therefor |
| BRPI0313290B1 (pt) * | 2002-08-08 | 2016-12-06 | Kissei Pharmaceutical | derivados de pirazol, promedicamento, composição farmacêutica, agentes terapêuticos e uso medicinal |
| CN100351263C (zh) * | 2002-08-08 | 2007-11-28 | 橘生药品工业株式会社 | 吡唑衍生物、含该衍生物的医药组合物、其医药用途及用于制备的中间体 |
| JP2004137245A (ja) | 2002-08-23 | 2004-05-13 | Kissei Pharmaceut Co Ltd | ピラゾール誘導体、それを含有する医薬組成物、その医薬用途及びその製造中間体 |
| DE102004028241B4 (de) | 2004-06-11 | 2007-09-13 | Sanofi-Aventis Deutschland Gmbh | Neue Fluorglykosidderivate von Pyrazolen, diese Verbindungen enthaltende Arzneimittel und Herstellung dieser Arzneimittel |
| RU2437876C2 (ru) * | 2006-05-19 | 2011-12-27 | Тайсо Фармасьютикал Ко., Лтд. | Соединение с-фенилглицитола для лечения диабета |
| ES2548578T3 (es) | 2007-12-27 | 2015-10-19 | Kissei Pharmaceutical Co., Ltd. | Monosebacato de un derivado de pirazol |
| PE20120648A1 (es) | 2009-02-23 | 2012-05-31 | Taisho Pharmaceutical Co Ltd | Compuestos de 4-isopropilfenilglucitol como inhibidores de sglt1 |
| BR112012007349A2 (pt) | 2009-10-02 | 2019-09-24 | Sanofi Sa | uso de composto com atividade inibidora de sglt-1/sglt-2 para produção de medicamentos para tratamento de doenças ósseas. |
| US8163704B2 (en) | 2009-10-20 | 2012-04-24 | Novartis Ag | Glycoside derivatives and uses thereof |
| UA113086C2 (xx) * | 2012-05-10 | 2016-12-12 | Піразольні сполуки як інгібітори sglt1 |
-
2014
- 2014-10-24 AR ARP140104010A patent/AR098670A1/es not_active Application Discontinuation
- 2014-10-26 JO JOP/2014/0310A patent/JO3485B1/ar active
- 2014-10-27 TW TW103137067A patent/TWI655198B/zh active
- 2014-10-30 DK DK14802974.7T patent/DK3066108T3/da active
- 2014-10-30 CN CN201480060924.9A patent/CN105705509B/zh active Active
- 2014-10-30 PT PT14802974T patent/PT3066108T/pt unknown
- 2014-10-30 MY MYPI2016701635A patent/MY192242A/en unknown
- 2014-10-30 PE PE2016000546A patent/PE20160884A1/es unknown
- 2014-10-30 SI SI201430941T patent/SI3066108T1/sl unknown
- 2014-10-30 EA EA201690749A patent/EA028801B1/ru not_active IP Right Cessation
- 2014-10-30 EP EP14802974.7A patent/EP3066108B1/en active Active
- 2014-10-30 MX MX2016005999A patent/MX368174B/es active IP Right Grant
- 2014-10-30 UA UAA201603973A patent/UA118767C2/uk unknown
- 2014-10-30 US US15/026,427 patent/US9573970B2/en active Active
- 2014-10-30 RS RS20181382A patent/RS58050B1/sr unknown
- 2014-10-30 PL PL14802974T patent/PL3066108T3/pl unknown
- 2014-10-30 HR HRP20182061TT patent/HRP20182061T1/hr unknown
- 2014-10-30 LT LTEP14802974.7T patent/LT3066108T/lt unknown
- 2014-10-30 JP JP2016526778A patent/JP6197113B2/ja active Active
- 2014-10-30 ES ES14802974T patent/ES2703944T3/es active Active
- 2014-10-30 AP AP2016009180A patent/AP2016009180A0/en unknown
- 2014-10-30 NZ NZ718118A patent/NZ718118A/en unknown
- 2014-10-30 CA CA2925128A patent/CA2925128C/en active Active
- 2014-10-30 AU AU2014347065A patent/AU2014347065B2/en active Active
- 2014-10-30 TN TN2016000112A patent/TN2016000112A1/en unknown
- 2014-10-30 WO PCT/US2014/063161 patent/WO2015069541A1/en not_active Ceased
- 2014-10-30 KR KR1020167011764A patent/KR101858881B1/ko active Active
- 2014-10-30 MA MA39019A patent/MA39019A1/fr unknown
-
2016
- 2016-03-17 DO DO2016000067A patent/DOP2016000067A/es unknown
- 2016-04-04 IL IL24489916A patent/IL244899B/en active IP Right Grant
- 2016-04-06 CR CR20160165A patent/CR20160165A/es unknown
- 2016-04-06 CL CL2016000791A patent/CL2016000791A1/es unknown
- 2016-05-03 SV SV2016005190A patent/SV2016005190A/es unknown
- 2016-05-06 PH PH12016500851A patent/PH12016500851B1/en unknown
-
2018
- 2018-12-12 CY CY181101334T patent/CY1121096T1/el unknown
-
2021
- 2021-11-17 AR ARP210103177A patent/AR124083A2/es unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EP3055318A4 (en) | Dihydroxyalkyl substituted polygalactomannan, and methods for producing and using the same | |
| EP3038466A4 (en) | 2,2-difluorodioxolo a2a receptor antagonists | |
| EP3025175A4 (en) | Single large mode cladding amplification in active double-clad fibers | |
| EP2985282A4 (en) | Glutarimide derivatives, use thereof, pharmaceutical composition based thereon and methods for producing glutarimide derivatives | |
| EP3204342A4 (en) | Compositions, panels and sheets comprising cellulose filaments and gypsum and methods for producing the same | |
| PL2912030T3 (pl) | Ulepszony sposób wytwarzania 5-(2,6-di-4-morfolinylo-4-pirymidynylo)-4- trifluorometylopirydyno-2-aminy | |
| IL236081A (en) | METHOD FOR PRODUCING 4- [5- (pyridine-4-ram) -1,2,4- h1- triazole-3-ram] pyridine-2-carbonitrile and intermediate phase thereof | |
| EP3095328A4 (en) | Prolonged-action acaricide composition and production method, acaricide strip and method for controlling the varroa destructor mite | |
| IL267303B (en) | Method for the production of -7-(3,4-dichloro-2-fluorophenylamino)-4)-4)-1 methoxyquinazolin-6-yloxy)piperidin-1-yl)prop-2-en-1-one | |
| EP3233088A4 (en) | Solid forms comprising (1e, 4e)-2-amino-n,n-dipropyl-8-(4-(pyrrolidine-1-carbonyl)phenyl)-3h-benzo[b]azepine-4-carboxamide, compositions thereof, and uses thereof | |
| EP3007256A4 (en) | Electrode binder composition, and electrode | |
| LT3066108T (lt) | 4-{4-[(1e)-4-(2,9-diazaspiro[5.5]undec-2-il)but-1-en-1-il]-2-metilbenzil}-5-(propan-2-il)-1h-pirazol-3-ilo beta-d-gliukopiranozido acetatas | |
| EP3013958A4 (en) | Glucan-encapsulated sirna for treating type 2 diabetes mellitus | |
| EP3029008A4 (en) | Silicon nitride-based sintered body, and corrosion-resistant member, sliding member and member for paper-making machine each manufactured using same | |
| EP3319158A4 (en) | FRAMEWORK FOR FUEL CELL AND FUEL CELL STACK STRUCTURE THEREWITH | |
| EP2999818A4 (en) | Paper composition and process for making the same | |
| TH1601002568A (th) | 4-{4-[(1e)-4-(2,9-ไดอะซะสไพโร[5.5]อันเดค-2-อิล)บิวท์-1-เอ็น-1-อิล]-2- เมธิลเบนซิล}-5-(โพรแพน-2-อิล)-1h-ไพเเรซอล-3-อิล เบทา-d-กลูโคไพแรโนไซด์ แอซิเทท | |
| EP3024415A4 (en) | Advancing genetic gain in bovine | |
| Stake et al. | Partnering-en form av samarbete: En fallstudie av partneringsprojektet Brygguddens Etapp 1 i Karlstad | |
| AU2013904145A0 (en) | secret connectors no.1 | |
| AU2013904769A0 (en) | My Personal Relief, My Pal | |
| AU2017901242A0 (en) | Improvements in biodiesel production | |
| AU2015903233A0 (en) | Improvements in bedding | |
| AU2013904452A0 (en) | SCUM-Australian Whiskey, Australia's Spirit! | |
| AU2013904119A0 (en) | Rolla bale |